12/26
06:51 am
tvtx
Why Travere Therapeutics Stock Popped by Nearly 14% on Wednesday [Yahoo! Finance]
Low
Report
Why Travere Therapeutics Stock Popped by Nearly 14% on Wednesday [Yahoo! Finance]
12/25
07:00 pm
tvtx
Is Travere Therapeutics Still Attractively Priced After Its 135% Share Price Surge? [Yahoo! Finance]
Low
Report
Is Travere Therapeutics Still Attractively Priced After Its 135% Share Price Surge? [Yahoo! Finance]
12/25
07:00 pm
tvtx
Why Travere Therapeutics (TVTX) Is Up 18.9% After FDA Eases FILSPARI Oversight And Delays Adcom [Yahoo! Finance]
Low
Report
Why Travere Therapeutics (TVTX) Is Up 18.9% After FDA Eases FILSPARI Oversight And Delays Adcom [Yahoo! Finance]
12/25
07:00 pm
tvtx
Travere Therapeutics (TVTX): Valuation Check After FDA Tailwinds and FSGS Expansion Hopes for FILSPARI [Yahoo! Finance]
Low
Report
Travere Therapeutics (TVTX): Valuation Check After FDA Tailwinds and FSGS Expansion Hopes for FILSPARI [Yahoo! Finance]
12/11
05:00 pm
tvtx
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/29
03:35 am
tvtx
Travere Therapeutics (NASDAQ:TVTX) was downgraded by analysts at
Wall St
Low
Report
Travere Therapeutics (NASDAQ:TVTX) was downgraded by analysts at
Wall St
11/28
08:00 am
tvtx
Travere Therapeutics (NASDAQ:TVTX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $47.00 price target on the stock.
Medium
Report
Travere Therapeutics (NASDAQ:TVTX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $47.00 price target on the stock.
11/26
08:18 am
tvtx
Why IBD 50's No. 3 Stock, Travere Therapeutics, Has Doubled In 2025 [Yahoo! Finance]
Low
Report
Why IBD 50's No. 3 Stock, Travere Therapeutics, Has Doubled In 2025 [Yahoo! Finance]
10/30/2025
04:01 pm
tvtx
travere therapeutics, inc.
BEAT
Report
18.6%
travere therapeutics, inc.
8/6/2025
04:01 pm
tvtx
travere therapeutics, inc.
BEAT
Report
-1.9%
travere therapeutics, inc.
5/1/2025
04:01 pm
tvtx
travere therapeutics, inc.
BEAT
Report
1.9%
travere therapeutics, inc.
2/20/2025
04:01 pm
tvtx
travere therapeutics, inc.
BEAT
Report
-6.8%
travere therapeutics, inc.
12/29
06:28 am
tvtx
Form 144 Travere Therapeutics, Filed by: ROTE WILLIAM E.
Neutral
Report
Form 144 Travere Therapeutics, Filed by: ROTE WILLIAM E.
12/16
04:23 pm
tvtx
Form 4 Travere Therapeutics, For: Dec 15 Filed by: Calvin Sandra
Medium
Report
Form 4 Travere Therapeutics, For: Dec 15 Filed by: Calvin Sandra
12/15
04:05 pm
tvtx
Form 144 Travere Therapeutics, Filed by: Calvin Sandra
Medium
Report
Form 144 Travere Therapeutics, Filed by: Calvin Sandra
12/3
04:30 pm
tvtx
Form 4 Travere Therapeutics, For: Dec 01 Filed by: Cline Christopher R.
Low
Report
Form 4 Travere Therapeutics, For: Dec 01 Filed by: Cline Christopher R.
12/1
04:10 pm
tvtx
Form 144 Travere Therapeutics, Filed by: Cline Christopher R.
Medium
Report
Form 144 Travere Therapeutics, Filed by: Cline Christopher R.
11/14
06:28 pm
tvtx
Form SCHEDULE 13G/A Travere Therapeutics, Filed by: ARMISTICE CAPITAL, LLC
Low
Report
Form SCHEDULE 13G/A Travere Therapeutics, Filed by: ARMISTICE CAPITAL, LLC
11/14
12:50 pm
tvtx
Form SCHEDULE 13G/A Travere Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
Low
Report
Form SCHEDULE 13G/A Travere Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
11/6
04:05 pm
tvtx
Form 4 Travere Therapeutics, For: Nov 04 Filed by: Calvin Sandra
Low
Report
Form 4 Travere Therapeutics, For: Nov 04 Filed by: Calvin Sandra
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register